PLK1 and neoplasm: In vitro and in vivo experiments demonstrated the excellent performance of the CS-CD with a shell of siRNA in the following areas: entering cancer cells, efficient down-regulation of Plk1 gene (regulates mitosis and is often overexpressed in tumor cells), and potent tumor inhibition effects [141].